Dec 17, 2021
Dec 13, 2021
Combo with immunotherapy drug can be effective in patients who are not good candidates for chemo
Dec 11, 2021
Analyses presented at ASH 2021 find statistical models can predict risk of early death with non-intensive AML therapy
Dec 9, 2021
Results at SABCS show assay has prognostic value that complements value of recurrence score in postmenopausal patients
Dec 3, 2021
Effectively joining SWOG’s work: A how-to for young investigators
Dec 1, 2021
RxPONDER finds postmenopausal women with HR+, HER2- breast cancer with 1-3 involved nodes and an RS of 25 or less can safely skip chemo
Nov 26, 2021
Nov 19, 2021
SWOG has opened a search for a vice chair for diversity, equity, inclusion, and professional integrity
Nov 10, 2021
Our grants largely fund today – Hope invests in tomorrow